Attendees
Sponsors and
Exhibitors
Media
Contact us
Blog
Orbis Protect RedAlert Identity Badge
RedAlert ID Badge is a personal alarm device with a full range of functionality for lone workers, boasting a discreet design that doubles up as an identity card holder. For more information click here.
Read moreatai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917
Atai Life Sciences a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and its subsidiary GABA Therapeutics, announced final positive results from a Phase 1 clinical trial of GRX-917 that were previously announced as preliminary results during…
Read moreContent Guru Extends Conversational AI Capabilities To Digital Channels
Content Guru, Europe’s leading cloud contact center and customer experience (CX) technology provider, announced the global availability of enhanced conversational AI features within its storm® Machine Agent™ intelligent automation suite. Read more here.
Read moreThe future of women's health: unlocking innovation
The future of women's health is likely to see continued advancements in technology and research, leading to better understanding and treatment of health issues specific to women. Read on for Thrive Wearables' findings from an insightful panel featuring leaders in the…
Read moreCheck out EMJ Innovations 7.1 2023!
Check out the latest issue of EMJ Innovations! Read the key updates in medical technology and digital health with a selection of review and feature articles. Read on for insights from the annual World Health Summit (WHS) 2022, which partnered with…
Read moreHuma CEO says UK risks falling behind on digital health
The CEO of Huma Health, Dan Vahdat, has warned that the NHS risks falling behind countries including US, Germany and France on adoption of digital health unless it aligns funding. Read more here.
Read moreGJE has been listed as a recommended firm in the JUVE Patent UK Rankings 2023
GJE has been listed as a recommended firm in the JUVE Patent UK Rankings 2023. The firm also received a new recommendation in the pharma and biotechnology field. Read more here.
Read moreWhy the uptake of innovative medicines matters now more than ever
One of Newmarket Strategy managers, Cristina Ruiz de Villa, has written an opinion piece in response to the article published this week by The Association of the British Pharmaceutical Industry (ABPI) and NHS Confederation on the ‘true cost of variation in uptake of innovative medicines’.…
Read moreObjectivity & Siemens Digital Industries Software Masterclass
Join Objectivity and Siemens for our online masterclass series where we’ll be exploring low-code solutions for a range of common use cases in the manufacturing industry. Read more here.
Read moreInvitation to NexMed Health
NextMed Health (the evolution of the Exponential Medicine conference) and chaired by Dr. Daniel Kraft, is happening this March 13-16th in San Diego, at the iconic Hotel del Coronado in San Diego. Join 60 world-class faculty, 500 selected participants and 60 innovative startups in the NextMed Innovation Lab for 4 days exploring the convergence of accelerating technologies, health(care) and biomedicine. NextMed faculty include GIANT's Shafi Ahemd, the NHS' Tony Young, and Genomic Englands' Baroness Nicola Blackwood. Register directly and use the registration code GIANT-FRIEND for a $500 savings.
Read moreAlio Raises $18M in First Close of Series C Financing
Alio announces its latest round of funding. a medical technology company reinventing the management of chronic disease, announced it has raised $18 million in the initial close of a Series C financing, bringing the total amount the company has raised to…
Read moreIndia’s Manipal Hospitals partners with Isansys Lifecare to launch remote patient monitoring technology
Isansys Lifecare has partnered with Manipal Hospitals in India where its ground-breaking remote patient monitoring system will be used to continuously monitor high risk and vulnerable patients. Read more here.
Read more